Suven Life Sciences Limited
NSE: SUVEN.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Venkateswarlu Jasti
- Employees
- 141
- Headquarters
- Hyderabad, India
- IPO year
- 2003
- Market cap
- ₹49.9B
- Website
- https://www.suven.com
Loading SUVEN…
Loading profile data…Frequently asked questions about SUVEN
What does Suven Life Sciences Limited (SUVEN.NS) do?
Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders in India, the United States, Europe, and internationally. The company engages in drug discovery and development of new chemical entities (NC...
Where does SUVEN.NS trade?
Suven Life Sciences Limited (SUVEN.NS) trades on the National Stock Exchange of India.
What sector is SUVEN.NS in?
Suven Life Sciences Limited (SUVEN.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Suven Life Sciences Limited?
Venkateswarlu Jasti is the chief executive officer of Suven Life Sciences Limited (SUVEN.NS).
Where is Suven Life Sciences Limited headquartered?
Suven Life Sciences Limited is headquartered in India.
Does SUVEN.NS pay a dividend?
Suven Life Sciences Limited (SUVEN.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SUVEN.NS go public?
Suven Life Sciences Limited (SUVEN.NS) completed its initial public offering in 2003.